Kelly N. Isbell

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 3 papers. Top paper: “Deactivation of STAT3 and ERK and Activation of p38 in Ovarian Cancer Cells Treated with a Small Molecule Inhibitor of PTP4A3 Phosphatase”.

Deactivation of STAT3 and ERK and Activation of p38 in Ovarian Cancer Cells Treated with a Small Molecule Inhibitor of PTP4A3 Phosphatase

The FASEB Journal(2022)10.1096/fasebj.2022.36.s1.r2345

N/A

0DataRank · unranked

0 citations

Kelly N. Isbell, Ettore J. Rastelli, Peter Wipf, Elizabeth R. Sharlow, John S. Lazo

Disruption of Ovarian Cancer STAT3 and p38 Signaling with a Small-Molecule Inhibitor of PTP4A3 Phosphatase

Journal of Pharmacology and Experimental Therapeutics(2023)10.1124/jpet.122.001401

N/A

0DataRank · unranked

11 citations

Kelly N. Isbell, Sai Ashish Vasa, Danielle C. Llaneza, Ettore J. Rastelli, Peter Wipf +2 more

Deletion of PTP4A3 phosphatase in high-grade serous ovarian cancer cells decreases tumorigenicity and produces marked changes in intracellular signaling pathways and cytokine release

Journal of Pharmacology and Experimental Therapeutics(2024)10.1124/jpet.124.002110

N/A

0DataRank · unranked

3 citations

Kelly N. Isbell, Sai Ashish Vasa, Danielle C. Llaneza, Garnett A. Mingledorff, Elizabeth R. Sharlow +1 more